![Weight-loss drugmaker Novo Nordisk invests $1.2 bn in new factory in Denmark](https://thepeninsulaqatar.com/assets/cdn/images/placeholder.jpg)
Weight-loss drugmaker Novo Nordisk invests $1.2 bn in new factory in Denmark
The Peninsula
Copenhagen: Danish pharmaceutical giant Novo Nordisk, maker of diabetes and weight loss treatments Ozempic and Wegovy, said Monday it was investing 8....
Copenhagen: Danish pharmaceutical giant Novo Nordisk, maker of diabetes and weight-loss treatments Ozempic and Wegovy, said Monday it was investing 8.5 billion kroner ($1.2 billion) to build a new factory in Denmark to produce drugs against rare diseases.
The 40,000-square-metre (430,000-square-feet) production facility and warehouse in Odense "marks the first time in this century that Novo Nordisk breaks ground in Denmark by establishing a new production site," the company said in a statement.
"Designed to be modular and flexible, it will accommodate multiple product types within rare disease, such as haemophilia, both now and in the future," Novo Nordisk said.
Henrik Wulff, executive vice president at Novo Nordisk, said the facility would help the company "meet the growing global demand for our life-changing medicines".
In November, the drugmaker posted a 21-percent rise in net profit to 27.3 billion kroner ($3.85 billion) for the July-to-September period, but lamented capacity limitations at its production sites.